Professor Bissan Al-Lazikani is Head of Data Science at the Institute of Cancer Research. There she leads the Big Data efforts to tackle key problems in Cancer drug discovery and Cancer therapy.

Bissan led the development of integrative computational approaches to inform drug discovery that are now internationally adopted and provided to the community via the canSAR knowledgebase. She applies data science and machine learning approaches to the discovery of novel therapies and pharmacological and radiation to adapting and individualising therapy to patients.

Bissan has a B.Sc (Hons) in Molecular Biology from University College London, an M.Sc in Computer Science from Imperial College and a PhD in Computational Biology from Cambridge University.

Bissan has worked on drug discovery and personalised medicine both in academia and industry.